BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19357701)

  • 1. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors.
    Garayoa M; Garcia JL; Santamaria C; Garcia-Gomez A; Blanco JF; Pandiella A; Hernández JM; Sanchez-Guijo FM; del Cañizo MC; Gutiérrez NC; San Miguel JF
    Leukemia; 2009 Aug; 23(8):1515-27. PubMed ID: 19357701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
    Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
    Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
    Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
    Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells.
    Redaelli S; Bentivegna A; Foudah D; Miloso M; Redondo J; Riva G; Baronchelli S; Dalprà L; Tredici G
    Stem Cell Res Ther; 2012 Nov; 3(6):47. PubMed ID: 23168092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
    Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
    Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
    Berry NK; Bain NL; Enjeti AK; Rowlings P
    J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
    Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
    Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell abnormalities in patients with multiple myeloma.
    Garderet L; Mazurier C; Chapel A; Ernou I; Boutin L; Holy X; Gorin NC; Lopez M; Doucet C; Lataillade JJ
    Leuk Lymphoma; 2007 Oct; 48(10):2032-41. PubMed ID: 17917971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.
    Smetana J; Dementyeva E; Kryukov F; Nemec P; Greslikova H; Kupska R; Mikulasova A; Ihnatova I; Hajek R; Kuglik P
    Neoplasma; 2014; 61(1):48-55. PubMed ID: 24195508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
    Schinke C; Qu P; Mehdi SJ; Hoering A; Epstein J; Johnson SK; van Rhee F; Zangari M; Thanendrarajan S; Barlogie B; Davies FE; Yaccoby S; Morgan GJ
    Clin Cancer Res; 2018 Jun; 24(12):2913-2919. PubMed ID: 29563136
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
    Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
    Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
    Mehdi SJ; Johnson SK; Epstein J; Zangari M; Qu P; Hoering A; van Rhee F; Schinke C; Thanendrarajan S; Barlogie B; Davies FE; Morgan GJ; Yaccoby S
    Br J Haematol; 2019 Feb; 184(4):578-593. PubMed ID: 30408155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients.
    Lucarelli E; Bellotti C; Mantelli M; Avanzini MA; Maccario R; Novara F; Arrigo G; Zuffardi O; Zuntini M; Pandolfi M; Sangiorgi L; Lisini D; Donati D; Duchi S
    J Transl Med; 2014 Apr; 12():95. PubMed ID: 24716831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological properties of mesenchymal stem cells derived from bone marrow of patients with multiple myeloma].
    Zhu BD; Ren J; Wang XY; Li X; Nie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1138-42. PubMed ID: 17204180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma.
    Lennon PA; Zhuang Y; Pierson D; Zhang X; Williams C; Perez C; Lin P
    Cancer; 2009 Jan; 115(2):345-54. PubMed ID: 19109814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism.
    Fernando RC; Mazzotti DR; Azevedo H; Sandes AF; Rizzatti EG; de Oliveira MB; Alves VLF; Eugênio AIP; de Carvalho F; Dalboni MA; Martins DC; Colleoni GWB
    Sci Rep; 2019 Jan; 9(1):1056. PubMed ID: 30705326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.